Rhythm Pharmaceuticals (RYTM) Change in Cash (2016 - 2026)

Rhythm Pharmaceuticals (RYTM) has 11 years of Change in Cash data on file, last reported at $7.9 million in Q1 2026.

• Change in Cash for Q1 2026 came in at $7.9 million, down 53.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$43.8 million (down 183.2% YoY), and the FY2025 annual result was -$34.8 million, down 219.14% from the prior year.
• Change in Cash advanced to $7.9 million in Q1 2026 per RYTM's latest filing, from $2.1 million in the prior quarter.
• Over five years, Change in Cash peaked at $108.2 million in Q2 2024 and troughed at -$114.1 million in Q3 2024.
• A 5-year average of $186000.0 and a median of $6.0 million in 2023 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2023 and 2024: Change in Cash plunged 193.4% in 2023, then jumped 1697.11% in 2024.
• A 5-year view of Change in Cash shows it stood at -$57.4 million in 2022, then surged by 92.14% to -$4.5 million in 2023, then soared by 1022.38% to $41.6 million in 2024, then sank by 95.02% to $2.1 million in 2025, then soared by 281.63% to $7.9 million in 2026.
• Business Quant data shows RYTM's Change in Cash at $7.9 million in Q1 2026, $2.1 million in Q4 2025, and -$83.4 million in Q3 2025.